Clearant Corporation, a biotechnology company, engages in the development and marketing of patent protected pathogen inactivation technology. The company develops and licenses the Clearant Process, a pathogen inactivation technology for biological products, such as tissue allograft implants, plasma therapies, blood products, and recombinant products. It markets its product through a direct sales force primarily in the United States and Europe. The company is headquartered in Los Angeles, California.